THW (Tekla World Healthcare Fund) ROCE %: % (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

THW Tekla World Healthcare Fund THW
57 GF Score
Price $14.23
GF Value $19.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tekla World Healthcare Fund ROCE %?

Tekla World Healthcare Fund THW +1.93% 57 ROCE % is % as of Mar. 2026. GuruFocus rates THW with a GF Score™ of 57/100 and a GF Value™ of $19.36 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

THW
57GF Score
Tekla World Healthcare Fund THW
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
Tekla World Healthcare Fund (THW) has a ROCE % of % as of Mar. 2026.
Is Tekla World Healthcare Fund's ROCE % too high?
Tekla World Healthcare Fund's current ROCE % is %. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's ROCE % compare to MUA and IQI?
Tekla World Healthcare Fund's ROCE % of % can be compared against companies in the Asset Management industry. The industry median ROCE % is 4.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Asset Management company?
The median ROCE % among Asset Management companies is 4.55, based on 713 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median ROCE % is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tekla World Healthcare Fund's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Modestly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $14.23 — trading 26.5% below its estimated fair value. The current ROCE % is %. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tekla World Healthcare Fund (THW) Overvalued in 2026?

Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued. The current stock price of $14.23 is trading 26.5% below its estimated GF Value™ of $19.36. GuruFocus considers Tekla World Healthcare Fund to be Modestly Undervalued.

Key valuation signals for THW:

  • ROCE %: %
  • GF Value™: $19.36 vs. price of $14.23 (26.5% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tekla World Healthcare Fund Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score

Get the complete analysis for THW

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.23
Price
$19.36
GF Value